Enzymes as therapeutic Targets for drug design Flashcards

(44 cards)

1
Q

Increased knowledge of protein structure and enzyme mechanism has allowed for what design?

A
  • inhibitor design - earlier approaches relied on trial and error
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the best inhibitors?

A

ones that mimic the transition state of the substrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the catalytic triad of a serine protease consist of?

A

His, Aspartate, serine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the basic mechanism of a serine protease?

A

It forms a covalent acyl enzyme intermediate - breaks down a complicated reaction into two easier steps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the catalytic strategies employed by a serine protease?

A
  • preferential binding of transition state
  • covalent catalysis
  • acid-base catalysis
  • electrostatic catalysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What forms the active site of a typical aspartyl protease?

A

-two homologous domains of protein - each of which provides one aspartate (H)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the catalytic strategies of aspartyl proteases?

A
  • acid-base catalysis

- preferential binding of the transition state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is HIV protease an exception to aspartyl proteases?

A

It acts as a homodimer with each subunit contributing an aspartyl (rather than two domains in a single polypeptide)

It is half the size of typical eukaryotic proteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are the aspartates close together in primary structure, in an aspartyl protease?

A

no! They are brought together through protein folding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of aspartyl proteases, including HIV protease?

A
  1. two aspartates - one protonated, one deprotonated
  2. one aspartate is a base - abstracts a proton from water
  3. activated water forms a tetrahedral transition state
  4. the other aspartate acts as an acid and donates a H+ to breakdown the intermediate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is the HIV protease essential to the HIV virus?

A

Yes - for viral maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the biggest problem in designing HIV protease inhibitors?

A

The active site is hydrophobic, but drugs must be hydrophilic enough to allow delivery in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What treatment is highly successful in treating AIDS?

A

HAART - highly active anti-retroviral therapy -combo of inhibitors of:

  • HIV protease
  • reverse transcriptase
  • integrase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is HAART successful in doing?

A
  • reducing viral RNA levels

- inc CD4 cell levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the function of a reverse transcriptase?

A

It makes the first DNA strand from a ssRNA as a template in order to integrate the viral genome into the host genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the function of integrase?

A

catalyzes the integration of the dsDNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the function of the HIV-1 Protease

A

cleaves the polyprotein (translation product) - release of viral proteins essential for maturation and infectitvity (such as RT and integrase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the specificity of the HIV protease?

A
  • NOT absolute sequence
  • large active site crevice - highly hydrophobic
  • formation of multiple tight hydrophobic contacts with amino acids around the active site
19
Q

Which are the active site aspartates in HIV protease?

A

Asp25 and Asp25’

20
Q

What is a function of the conformational change when substrate binds to HIV protease?

A

It has flaps that sequester the substrate from water (except the oriented H20 involved in the rxn)

21
Q

What is the shape of the transition state in all aspartyl protease reactions?

22
Q

How should you design transition state analogs? (3 steps)

A
  1. inhibitors which look like substrates - recognition
  2. introduce a non-hydrolyzable bond where peptide bond would be
  3. incorporate tetrahedryl geometry into these inhibitors
23
Q

What are some ways that you can test the effectiveness of an inhibitor?

A
  • Ki
  • virus production by an infected cell culture
  • pharmacological properties
  • water solubility
  • stability
  • inhibition of other similar enzymes (other aspartyl proteases in this case)
  • effectiveness and toxicity in animals and humans
24
Q

What are two results of using substrate-based design for HIV protease inhibitors?

A
  1. all inhibitors bind at enzyme’s active site

2. all inhibitors have some structural similarity

25
Is substrate-based design or enzyme-based design more prominent?
substrate-based
26
What is the concept of enzyme-based design?
computer programs pick known molecules that are predicted to "fit" into the active site
27
Was enzyme-based design useful in designing HIV protease inhibitors?
No - but useful for other targets
28
What are some clinical problems with HAART and HIV protease inhibitors?
1. resistance 2. pharmacokinetics 3. accessing reservoirs of virus 4. cost and availability 5. side-effects/ long-term toxicity 6. patient compliance 7. When to initiate treatment
29
Why do patients become resistant to HIV-1 drugs?
- High error rate of RT - large number of virus particles made -some of these sequences will encode viral proteins that can perform normal function and not bind inhibitor
30
The HIV-1 protease in resistant virus must be able to: (2)
1. insensitive to drug - high Ki | 2. able to carry out normal catalytic activity efficiently - kcat/Km= WT
31
Is a virus variant that is not able to replicate rapidly, but still able to replicate, in the presence of a protease inhibitor dangerous?
Yes - the production of new mutations in the viral genome can still occur
32
What is a solution to resistance to HIV-protease inhibitors?
Combinations of anti-HIV drugs against different targets - HAART
33
What is the first direct antiviral against HCV?
HCV protease inhibitors
34
What are two broad categories of enzyme regulation?
1. regulation of enzyme activity | 2. regulation of enzyme availability
35
How is the activity of an allosteric enzyme regulated?
1. by levels of its own substrate or 2. levels of other activating or inhibitory modulators
36
What is K0.5?
concentration of substrate giving half -maximal activity - aprox equivalent to km
37
What is the effect of an allosteric activator on k0.5?
activators decrease K0.5
38
What is the effect of an allosteric inhibitor on K0.5?
inhibitors increase k0.5
39
Do allosteric enzymes follow typical Michaelis-Menten equations?
No0o0o
40
Even though there is a strong resemblance between hemoglobin and allosteric enzymes, and myoglobin and michaelis-menten enzymes, what are you actually looking at?
Hemoglobin and Myoglobin: substrate binding Allosteric and Michaelismenten: reaction rates
41
What is the general model for the regulation of allosteric enzymes?
-Binding at an allosteric site changes conformation of the enzyme so that other sites are affected
42
CTP is an allosteric _____ of ATCase
Inhibitor - stabilizes low affinity conformation -Tstate - active sites less available - shifts RIGHT
43
ATP is an an allosteric _____ of ATCase
activator - stabilizes the high affinity conformation - R state - active sites more accessible - Shifts LEFT
44
Are CTP or ATP substrates of ATCase?
NOO - must bind at other locations other than the active site (allosteric enzyme DUuUuH)